Global Health Data Exchange - Discover the World's Health Data

The potential cost and benefits of raltegravir in simplified second-line therapy among HIV infected patients in Nigeria and South Africa

Nav

General Info
Geography 
Nigeria (NGA)
Coverage type 
Country
Time period covered 
01/2011 - 12/2012